Category Archives: BioUtah News
IONIQ Sciences recognized as “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology Company 2021″
IONIQ Sciences, Inc. announced it has been awarded “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology Company 2021” by Global 100.
Clene Nanomedicine’s Patent Portfolio Grows to More Than 150 Issued Worldwide, including Two Key Patents Now Validated Across Europe
Powerful combination of key patents comes as the Company looks ahead to topline results from a Phase 3 registration study in ALS in second half of 2022.
Clene Nanomedicine to Present RESCUE-ALS Phase 2 Data in Late-Breaking Session at 32nd International Symposium on ALS/MND
Clene presented data from the RESCUE-ALS Phase 2 study of CNM-Au8®, a catalytically active gold nanocrystal suspension, for the treatment of amyotrophic lateral sclerosis (ALS).
Pfizer to Acquire Arena Pharmaceuticals
Arena Pharmaceuticals, Inc. and Pfizer Inc. have entered into a definitive agreement under which Pfizer will acquire Arena.
IONIQ’s breast cancer feasibility results published by IEEE
Salt Lake City, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. (“IONIQ” or the “Company”), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our ‘breakthrough’ bioimpedance technology in breast cancer. “Skin Electrical Resistance as a Diagnostic […]
Recursion loops in Roche, Genentech for multibillion-dollar AI drug discovery deal
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.
ARUP Laboratories Earns Fourth Consecutive Utah Business Best Companies To Work For Award
For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
Renalytix reported financial results for the quarter ended September 30, 2021.
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology
The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.
Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test
Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).
Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India
Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.
